Susannah E. Motl
University of Tennessee College of Pharmacy
Memphis 38163
USA
Name/email consistency: high
- Evaluating the accuracy of health news publications in a drug literature evaluation course. Motl, S.E., Timpe, E.M., Eichner, S.F. Am. J. Pharm. Educ (2006)
- Bevacizumab in combination chemotherapy for colorectal and other cancers. Motl, S. Am. J. Health. Syst. Pharm (2005)
- Delayed-onset grade 4 neutropenia associated with rituximab therapy in a patient with lymphoma: case report and literature review. Motl, S.E., Baskin, R.C. Pharmacotherapy (2005)
- Evaluation of accuracy of health studies reported in mass media. Motl, S.E., Timpe, E.M., Eichner, S.F. J. Am. Pharm. Assoc. (2003) (2005)
- Technology evaluation: Canvaxin, John Wayne Cancer Institute/CancerVax. Motl, S.E. Curr. Opin. Mol. Ther. (2004)
- Proposal to improve MedWatch: decentralized, regional surveillance of adverse drug reactions. Motl, S., Timpe, E., Eichner, S. Am. J. Health. Syst. Pharm (2004)
- Recurring chemotherapy-associated alopecia areata: case report and literature review. Motl, S.E., Fausel, C. Pharmacotherapy (2003)
- Programs established by FDA to expedite patient access to medications. Motl, S., Miller, S.J., Burns, P. Am. J. Health. Syst. Pharm (2003)









